Nuclear Medicine Market size was valued at USD 5.5 Bn. in 2021 and the total Insulation revenue is expected to grow by 14.7 % from 2022 to 2029, reaching nearly USD 18.9 Bn.
Nuclear Medicine Market Overview:
The study “Nuclear Medicine Market” aims to give cutting-edge market knowledge and assist decision-makers in making informed investment decisions. It also provides a detailed analysis of the global Nuclear Medicine Market by Product Type, End Users/Application, Key Manufacturers, and Several Key Regions.
Market Scope:
The study focuses on the report’s growth possibilities, restrictions, and market analysis. The study uses Porter’s five forces analysis of the Nuclear Medicine industry to evaluate the influence of different factors such as supplier bargaining power, competitors, and competitive intensity
Request for Sample@ https://www.maximizemarketresearch.com/request-sample/98418
Segmentation:
The therapeutic market is further segmented into brachytherapy, alpha emitters, and beta emitters. The segment growth could be fueled by the segment’s strong product pipeline along with the approval and commercialization of nuclear medicine.For instance, diffusing alpha-emitters radiation therapy (DaRT) was approved and given breakthrough designation by the U.S. FDA in October 2021 for the treatment of patients with recurrent glioblastoma multiforme (GBM). When other treatments failed to help GBM patients, this therapy was used alone. Radium (Ra-223) is currently the most popular alpha emitter in therapeutics. Growth of the Nuclear Medicine market is anticipated to be boosted by the development of prospective radioisotopes such Terbium (Tb-149), Bismuth (Bi-212), and Actinium (Ac-225).
Key Players:
• Cardinal Health
• GE Healthcare
• Bayer
• Bracco Imaging
• Curium
• Lantheus Medical Imaging Inc.
• Nordion Inc
• Advanced Accelerators Applications
• Mallinckrodt Pharmaceuticals
• Jubliant Lifesciences
• Medtronics plc
• Norgine BV
• Traid Isotopes
• Siemens Healthineers AG
The research offers a competitive landscape based on a thorough examination of the important strategic advancements implemented by the top market participants in the Nuclear Medicine sector throughout time. The main players in the worldwide Nuclear Medicine market are as follows:
Regional Analysis:
The report has assessed the global Nuclear Medicine market in the following regions:
- America, North (the United States, Canada)
- European Union (Germany, France, United Kingdom, Russia)
- Asia-Pacific region (China, Japan, Korea, India, Southeast Asia, and Australia)
- Latin America (Brazil, Argentina, Colombia)
- Africa and the Middle East (Saudi Arabia, UAE, Egypt, South Africa)
The study includes in-depth insights into multiple development possibilities and difficulties in the aforementioned regions, depending on various types of commodities, applications, end-users, and nations, among others. The study also contains essential aspects of the global Nuclear Medicine market, such as sales growth, product pricing and analysis, growth potential, and recommendations for addressing market difficulties in the provided areas.
COVID-19 Impact Analysis on Nuclear Medicine Market:
The worldwide effects of the coronavirus outbreak are already being seen and will have a considerable influence on the Nuclear Medicine market. The COVID-19 outbreak has had a wide-ranging impact, including flight cancellations, travel bans and quarantines, restaurant closures, and restrictions on all indoor/outdoor events; a state of emergency declared in over thirty countries; a massive slowdown of the supply chain; stock market; falling businesses, growing panic among the people, and uncertainty about the future.
Key Questions Answered in the Nuclear Medicine Market Report are:
- How is the competitive scenario of the Nuclear Medicine market?
- Which are the key factors affecting the Nuclear Medicine market growth?
- Which region holds the maximum share in the Nuclear Medicine market?
- What will be the CAGR of the Nuclear Medicine market during the forecast period (2021-2027)?
MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT Park Phase 2,
Pune Banglore Highway,
Narhe, Pune, Maharashtra 411041, India.
Email: [email protected]
Phone No.: +91 20 6630 3320
Website: www.maximizemarketresearch.com
